News > Page 88

• 

  Exploring the Pharmacokinetic Profile of STS101 in a Crossover Study

  5/8/2024
• 

  Advancements in Myotonic Dystrophy Treatment: The Launch of a New Phase 3 Trial for AMO-02

  5/8/2024
• 

  Understanding Tardive Dyskinesia Among Antipsychotic Users in the U.S.

  5/6/2024
• 

  Expanded Access Program for Foralumab in Progressive Multiple Sclerosis

  5/5/2024
• 

  Exploring New Frontiers in Cardiac Therapy for Friedreich Ataxia

  5/4/2024
• 

  Exploring the New Frontiers in Parkinson's Disease Treatment with ANPD001 Cell Therapy

  5/4/2024
• 

  Exploring the Connection Between Leptin Levels and Alzheimer's Disease Progression

  5/4/2024
• 

  Revolutionizing Tardive Dyskinesia Management: The Introduction of Valbenazine Sprinkle Formulation

  5/2/2024
• 

  New Advances in Alzheimer's Treatment: A Closer Look at ALZ-801's Clinical Trials

  5/2/2024
• 

  Revolutionizing Dementia Care: The Promise of AI-Enhanced Neurotechnology

  5/1/2024